Johnson & Johnson Statement on COVID-19 Vaccine (7/12)
The Pharma Data
JULY 12, 2021
Rare cases of the neurological disorder, Guillain-Barré syndrome have been reported following vaccination with the Janssen COVID-19 vaccine. Most occurred within 42 days after vaccination. For further information on the safety of authorized COVID-19 vaccines, please visit: [link]. What Is the Janssen COVID-19 Vaccine?
Let's personalize your content